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Abstract
Hematopoletlc precursors lacking T cell antigen receptors (TCR-CD3-) and CD4 and CD8 surface
markers (I.e. double-negative thymocytes) give rise to functionally mature T lymphocytes. Yet
their major progeny are Immunologlcally unresponsive thymocytes In spite of having acquired
TCR - CD3 and CD4 - CD8. Because only mature thymocytes migrate to peripheral lymphold
organs and most thymocytes die In situ, the knowledge of the events associated with functional
maturation In the double-negative thymocyte progeny Is a fundamental question in T cell
development. We reasoned that a clue to trace the fate of early human thymocytes may perhaps
come from the study of the developmental acquisition of CD1 antigen, currently used to define
better the functionally Inert CD4+8+ (double-positive) stage and absent In mature, medullary
thymocytes and peripheral T cells. By using antibodies specific for CD1 (HTA 1/T6) we show here
that a large fraction of double-negative thymocytes also express CD1. CD1 +3-, CD1 +3 + ,
CD1-3+, and CD1-3- subsets all exist. The CD1+3- subset generates CD1+3-4-8+ precursors
of CD1 + double-positive cells. A large portion of the CD1 +3+ subset bears TCR75-CD3
complexes. The CD1 - subsets are responsive In assays of function, in which they can be
stimulated to use the interleukin 2 pathway of proliferation and to mediate cytotoxiclty. In
contrast, all CD1 + thymocytes behave as functionally inert cells. Thus, the CD1 surface marker
delineates human thymocyte precursors and their products which lack, or possess, functional
potential In vitro, on both a/3 and 76 lineages.
Introduction
Triggering of resting peripheral T cells occurs through occupancy
of the antigen receptors, afl or 76 heterodimers associated with
CD3 (TCR - CD3 complex) and CD4 or CD8 co-receptors. TCR
ligands stimulate T cell proliferation via the antigen-non-specific,
interleukin 2 receptor (IL2-R)/IL2 growth pathway. Such activated,
mature T cells can mediate helper or cytotoxic effector functions
in an antigen-specific fashion upon a later occupancy of the TCR
0).
Acquisition of TCR-CD3, CD4, and CD8, as well as T cell
associated function programs, occurs during T cell development
in the thymus (2,3). Three sub-populations of thymocytes have
been defined on the basis of their antigen receptor phenotype
and their functional competence: early precursors and either
immunologically unresponsive (inert) or mature thymocytes (4,5).
The early thymocytes, which lack surface expression of
TCR - CD3, CD4, and CD8 receptors, give rise to some pheno-
typically and functionally mature thymocytes which can migrate
to the periphery (6). Yet their major progeny are functionally
unresponsive thymocytes, despite the fact that about half of them
co-express TCR - CD3, CD4, and CD8 on the membrane (5 - 9).
The events signaling the functional fate of early thymocyte
progeny are thus a fundamental question in T cell development
because inert thymocytes do not migrate to the periphery (7).
The most striking finding of the functional studies performed
with thymocytes is their lack of correlation with antigen receptor
expression (9-11). We reasoned that a clue to trace the
functional fate of early thymocytes may perhaps come from
developmental analyses of a third type of cell-surface marker that,
unlike TCR-CD3 complex or CD4 and CD8, were selectively
expressed on inert thymocytes. It has been previously shown
that CD1 (HTA 1/T6) occurs on functionally inert human
CD4+8+ double-positive thymocytes but not in immuno-
competent thymocytes or peripheral T cells (4,12 -14). We have
therefore studied the expression of CD1 on human early
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thymocytes using CD1-specific antibodies. We show here that
subsets of CD3- and CD3+ double-negative thymocytes also
express CD1 antigen on their surfaces. CD1 - subsets contain
mature a/3 and 76 T cells, whereas CD1 + subsets behave like
inert thymocytes belonging to a/3 and
 75 lineages.
Methods
Isolation of cells
Single cell suspensions were obtained from normal pediatric
thymus that had been removed during corrective cardiac surgery
of patients 2 weeks - 5 years old. Viable thymocytes were isolated
by Ficoll - Hypaque density centrifugation (15) Double-negative
thymocytes were isolated by immunoselection using cytotoxic
antibodies to CD4 (HP2/6) and CD8 (B9.4) plus a 1:4 dilution
of selected rabbit complement (Beringwerke, Marburg, FRG)
(3,15). The surviving cells (99% CD4-8-) were incubated with
either anti-CD1 (OKT6, 7, antibody) (CD1+3-4-8- cells), anti-
CD3 (T3b, 72a) antibody (CD1-3 + 4 - 8 - cells), or both
(CD1+3+4-8- and CD1-3-4-8- cells), and the respective
population positively or negatively selected after incubation with
affinity-purified rabbit anti-mouse immunoglobulm for 1 h at 4°C.
The CD1 +3+ subset behaves as total CD1 + cells For accuracy
in some experiments, including ones in this report, the minor
CD1 +3+ subset within the CD1 + or CD3+ selected population
was depleted by incubation with either cytotoxic CD3 (T3b) or
CD1 (Na1/34) antibodies plus complement. CD1 - 3 - 4 - 8 -
thymocytes express CD7 and CD2 T cell differentiation antigens
in vivo (15 and data not shown). CD3-4-8+ thymocytes were
isolated after two rounds of cytotoxic elimination with monoclonal
antibody (mAb) CD3 (T3b) and CD4 (0KT4A) plus complement
followed by positive selection with mAb CD8 (B9 4,
 72b) in flasks
coated with goat anti-mouse
 7 2 b antibodies (Southern
Biotechnology, Birmingham, AL, USA). Most recovered cells
expressed CD1. All purified populations were >98% pure by
FACS analyses An intracardiac blood sample was obtained
before establishment of the extracorporeal bypass circulation.
Mononuclear cells were separated by Ficoll - Hypaque density
centrifugation.
mAbs
CD1 [OKT6,
 71, American Type Culture Collection, Rockville,
MD, USA, Na1/34 (12),
 72a, or Coulter Clone T6, Coulter], CD2
[MAR 206.1 (16),
 7 l ] , CD3 [T3b (17), 72a, and Coulter Clone
T3], CD4 [HP2/6 y2 (16), Leu3a, Becton-Dickinson, 7,, or
OKT4A, Ortho, Rantan, NJ, USA,
 7 2 a ] , CD7 [3A1, American
Type Culture Collection, Rockville, MD], CD8 [B9.4 (18),
 7 2 b ] ,
TCRa/3 [WT31 (19),
 7 , ] , TCR75 [TCR51 (20), 7 1 ] , TCR-V,,,
[TCS61, T-cell Sciences, Boston, MA, USA], TCR-V^ [Ti-yA(21),
72a], and CD25 [Tac chain of the IL2R, H108 (16)] were used
Quantitative flow cytometry
Two-color immunofluorescence studies were carried out as
previously described (22). Cells were stained in sequential steps.
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Fig. 1. Two-color immunofluorescence FC analyses for coordinate expression of CD1, CD3, a&, and
 76 TCRs in CD4~8- thymocytes. Double-
negative thymocytes were isolated using cytotoxic antibodies to CD4 (HP2/6) and CD8 (B9.4) plus rabbit complement (Beringwerke, Marburg, FRG),
and two-color FC studies were carried out as described in Methods Briefly, thymocytes were stained by indirect immunofluorescence Reagents
included mAbs of predefined isotype CD1 [(b) OKT6,
 7 1 , or (e) Na1/34, 7 2 a ] , CD3 [T3b, 7 2 a ] , CD4 [Leu3a, 7 1 ] , CD8 [B9 4, 7 2 b ] , a/3 TCR [WT31,
7 1 ] , and y& TCR [TCR61, 7 1 ] , followed by either FITC (green)-conjugated or PE (red>labeled goat anti-mouse isotype-specific second step reagents.
Preliminary studies showed that each anti-isotype antibody did react with one but not the other primary antibody Experiments using directly labeled
antibodies yield similar results (Table 1). FC analyses were performed in a FACScan analyzer equipped with a four decade log amplifier and 104
viable cells were accumulated in each contour plot Background values are indicated by dotted lines. Percentages of positive cells in each quadrant
are indicated in the text for clarity Results are representative of six independent experiments.
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Reagents included mAbs of predefined isotype, as indicated,
followed by either fluorescein isothiocyanate (FITC; green)-
conjugated or phycoerythrin (PE; red)-labeled goat anti-mouse
isotype-specific second step reagents (Southern Biotechnology).
Background values are indicated by dotted lines and were
obtained using isotype-matched, irrelevant antibodies and their
respective second antibodies. These procedures rule out any
artifice due to carry over of mAb from the cytotoxic incubation
(23). Percentages of positive cells in each quadrant are indicated
in the text for clarity. Two-colour flow fluorocytometry (FC)
analyses were performed in a FACScan analyzer interfaced to
a Consort 30 (Beckton-Dickinson).
Assays for differentiation
CD1+3-4-8-or CD3-4-8+ cells were isolated from thymocyte
populations as indicated above. They were stained, either fresh
or after their culture in the presence of 50 U/ml rll_2 (3) for 36 h,
with mAbs specific for the indicated combinations of T cell
differentiation antigens and analyzed for two color immuno-
fluorescence and FC.
Assays for function
(i) To quantitate IL2 secretion, 2x10 6 cells in each double-
negative subset were stimulated with 5 /ig/ml phytohemagglutinm
(PHA) and 25 U rlL1|3 (Hoffmann-LaRoche, Inc , Nutley, NJ, USA)
for 36 h. Supernatants were collected and IL2 activity measured
using the IL2-dependent CTLL2 line in triplicate cultures, and
the sensitive hexoseammidase read-out assay (15). Units were
calculated as indicated (15) and compared to a rll_2 control
(Hoffmann-LaRoche, no. R023-6019). (n) The expression of the
p55 chain of the IL2R (Tac or CD25) was measured either on
freshly isolated thymocytes or after their stimulation (2X106
cells) with 5 ng PHA for 24 h, using biotin-conjugated anti-Tac
(H108) antibody followed by PE-labeled streptavidin (Becton-
Dickinson). (iii) Proliferative cell responses of 2X105 cells
cultured with either 50 U rlL2 or 5 /tg/ml PHA and 25 U rlL1/3
were carried out at 37°C for 80 h in triplicate cultures in 96-well
microtiter plates. pH]Methylthymidine uptake (1 ^Ci/well) was
measured during the last 11 h of culture (15) (iv) For quantrtation
of cytotoxic activity, effector cells were cultured for 4 days at 106
cells/ml in 50 U/ml rlL2. Their cytotoxic activity was assessed
against 51Cr-labeled P-815 cells either uncoated or coated (24)
with T3b (CD3)-, WT31 (TCRajS)-, or TCR61 (TCR7S)-specific
antibodies. MAR206.1 antibody (CD2) gave similar results to
those obtained with uncoated target cells (not shown) The 4 h
51Cr-release assay was performed as described elsewhere (24).
The results are expressed as the mean 51Cr specific release of
triplicate cultures at 25/1 effector-to-target ratio. Spontaneous
release never exceeded 18%.
Table 1. Detection of CD1 + TCR7S-CD3 + cells in the thymus but not in peripheral blood
Cells CD1 CD3 CD1^
CD3^
CD1 CD1 CD1 +
TCRVj, -
CD3 + TCRVj, + CD1 + cells in
CD3+ the TCR76+ subset
Total thymocytes
Double-negative
thymocytes
Peripheral blood
lymphocytes
83
61
< 1
69
38
73
47
17
< 1
13 5
4.7
1
23
1
ND
44
The indicated cell populations were isolated and two-color FC studies were carried out as described in Fig 1 Here direct immunofluorescence
was used. Antibodies in the upper row were conjugated with PE (red) and those in the lower row were FITC (green). The proportion of CD1 + cells
in the y& population was calculated by two-color FC measuring the number of CD1 + cells (red) after electronically gating in the TCR7<5 + subset
(green). Reagents were Coulter Clone T6 (CD1), Coulter Clone T3 (CD3), TCR51 (TCR76), Ti-7A (TCR-V^g), and TCS51 (TCR-V61) Results show the
percentages of positive cells in a child representative of four similar cases studied, ND, not done
Table 2. Immunological unresponsiveness of the CD1+ subset of CD4-8- double-negative thymocytes
Cell populations8 (a) IL2 secretion
(U/ml)
(b) Tac expression
positive cells)
(c) Proliferation
(cpm/minx 10 -3)
(d) Antibody retargeted cytotoxicrly
(% specific 51Cr release)
Total thymocytes
C D 1 - 3 - 4 - 8 -
CD1+3-4-8-
CD1-3+4-8-
CD1+3+4-8-
PHA + IL1/3
5.2
6 3
0 1
3 3
0.2
fresh
1
46
1
8
2
PHA activated
38
76
1
52
6
rlL2
3
87
0.9
15
1 8
PHA + rlL1|3
109
189
3
161
7
None
3
5
1
2
3
CD3
37
55a
2
68
3
TCRajS
30
38
1
49
2
TCR76
11
33
0
23
1
Function assays were (see Methods for details), (a) IL2 secretion promoted by PHA plus rlL1/3 was estimated using IL2-dependent mouse CTLL2
cells, which respond to human rlL2 but not rlL4, (b) Tac expression in fresh or PHA activated cells was evaluated using H108 antibody and flow
cytometry, (c) proliferation was measured by [3H]thymidine incorporation after 80 h of culture with rll_2 or PHA + rlL1/3; and (d) cytolytic potential
was assessed against 51Cr-labeled P-815 cells either uncoated or coated (24) with T3b (CD3)-, WT31 (TCRajS)-, or TCR61 (TCR75)-specific antibodies
CD2 antibody (MAR206 1, 7,) gave similar results to those obtained with uncoated target cells (not shown) The results are expressed as the mean
51Cr specific release of triplicate cultures at a 25/1 effector-to-target ratio Spontaneous release never exceeded 18%.
aSee Methods. The data presented here were obtained in a simultaneous experiment; similar results were obtained in five experiments
bCDI - 3 - 4 - 8 - thymocytes express CD7 and CD2 T cell differentiation antigens in I/7VO(15, and data not shown), and acquire TCR -CD3 complex
and cytotoxic activity upon culture with rlL2 (3,22)
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Results
Isolation of early T cell precursors from postnatal thymus requires
their separation from inert and mature thymocytes (3,4). In the
human system we have used anti-CD1 antibodies to aid in the
depletion of inert cells. Combined with anti-CD4 and anti-CD8
antibodies, we obtained a high proportion of TCR-CD3 +
mature thymocytes in the double-negative isolate (2,15). In the
mouse system others have used anti-CD5 antibody to aid in the
depletion of mature cells when preparing CD4-8- thymocytes
(6). Unexpectedly, anti-CD5 antibody treatment depletes the
above TCR-CD3+ mature subset of double-negative
thymocytes (26). We thought that perhaps the depletion of
CD1 + cells in our previous studies could have eliminated an
inert CD1+4-8- precursor subset (23)
We have now tested this possibility by using two-color
fluorescence staining and FC and assessing the co-ordinate
expression of CD1, TCRa/3-CD3, and TCR75-CD3 on total
CD4-8- thymocytes. Figure 1a shows that only CD4-8-
thymocytes are left after treatment of thymocytes with anti-CD4
and -CD8 cytotoxic antibodies and complement. Figure 1 b shows
the distribution of CD1 and CD3 surface molecules on double-
negative thymocytes. We found that 44% of double-negative
thymocytes were CD1+3-, 13% were CD1+3 + , 14% were
CD1-3-, and 29% were CD1-3 + . We also studied the
presence of TCRajS-CD3 + and TCR75-CD3 + thymocytes
among the double-negative thymocyte subset by using the pan-
TCRa/3 monoclonal antibody WT31 and anti-TCR51 antibody
specific for a framework determinant of the human TCR6 chain
We found among the population of double-negative thymocytes
29% TCR61+CD3 + , 13% WT31+CD3 + , and 58%
TCR51WT31-CD3- cells (Fig. 1c and d). We also found a
minor population CD3+TCR51+ (Fig. 1d) among the CD1 +
double-negatives (8-13%, Fig 1e). Similarly a CD1+3+WT31 +
minor subset also exists (1 - 6 % , data not shown) As shown in
Table 1, a subset of yd T cells in thymus but not in autologous
peripheral blood co-expresses TCR76 and CD1. Moreover,
studies using antibodies specific for TCRs using V^ g and Vj,
regions (21,27) showed a preferential use of V51 in the thymus
and V g^ in the periphery
Mature single-positive thymocytes respond to polyclonal T cell
activators (i e. PHA, anti-CD3 antibody) with IL2R expression,
IL2 secretion, proliferation, and subsequent expression of effector
functions (i.e. cytotoxicity) (1,5). We isolated the CD1+3 + ,
CD1+3-, CD1-3 + , and CD1-3- double-negative sub-
populations by panning and carried out a comparative study of
these functions with the purified double-negative thymocyte
subsets. Table 2a shows that the CD1+3- and CD1+3 +
populations, the CD1-positive subsets, did not secrete IL2 upon
stimulation with PHA plus ML113, while the CD1 -negative subsets,
either CD3- or CD3 + , did so. Approximately 46% unstimulated
CD1-3- double-negative thymocytes expressed IL2Ra
(Tac,p55); unstimulated CD1-3+ double-negative thymocytes
had barely detectable levels of IL2Ra but both the number of
positive cells and the levels of IL2Ra increased after their
stimulation with PHA. In contrast, CD1 + double-negative
thymocytes did not express IL2Ra under any of the conditions
studied (Tabfe 2b). The ability to express IL2Ra correlated well
with the proliferative responses driven by rll_2 alone or by PHA
plus rlL1/3 (Table 2c). The CD1 - 3 - double-negative population
exhibited the best responses to rlL2, the CD1 -3+ population
responded to a lesser extent and the CD1 + subsets were
unresponsive. The CD1-3 + , which can express IL2Ra after
Table 3. Mitogenic combination of either anti-CD2 or anti-CD3
antibodies stimulate proliferation in IL2 in CD1-3+ but not
CD1 +3+ double-negative thymocytes
Thymocyte subset8
CD1+3+4-8-
CD1-3+4-8-
Total
[3H]Thymidme
CD2 + ML2
d2 d3
2 2 3.7
17 33
5 13
d4
5
81
29
incorporation (cpm x 10
CD3 + rlL2
d2 d3
1b 18 32
24 47
8 19
d4
4.8
107
40
- 3 )
None
d2
2.3
1 2
0 8
d3
0.7
04
02
Thymocytes, 2 x 10s per microtiter tray well, were incubated for 2, 3,
or 4 days under the indicated culture conditions, rll_2 was added at
50 U/ml, the mitogenic pair of CD2 antibodies was D66 1 (38) + MAR
206 1, and anti-CD3 antibody was in solid phase (plate-bound, 1 /ig/ml
T3b) (39) Results represent the average counts of triplicate determinations
aThymocyte subsets were either unfractionated or fractionated as
indicated in Table 2
blt is noteworthy that a few proliferating cells occur in cultures of the
poorly responsive CD1+3+ double-negative subset. Phenotypic
analyses of these cells showed that they were CD1 - T cells (data not
shown)
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Fig. 2. Development in vitro of human double-positive thymocytes
CD1 + 3 - 4 - 8 - (a and b) or CD3-4-8+ (c and d) cells were isolated
and stained, either fresh (c) or after their culture in the presence of 50 U/ml
rlL2 for 36 h (a, b, and d), with CD8 (B9.4, 72b), (a) C D 3 0"3b ' Y2J. or
(b) CD4 (OKT4A, 72a) i n the indicated combinations, followed by the
respective isotype-specific, fluorochrome-conjugated second antibody.
Numbers in each contour-plot panel ( a - d) represent the percentage of
positive cells in every quadrant Note the CD3 + CD4 legend in panel
(c) indicates that cells were simultaneously incubated with CD3 and CD4
72a mAb followed by PE conjugated 72a-specific second antibody
Similar results were obtained with four independent thymuses
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activation (Table 2b), exhibited proliferate responses to PHA
plus rlL1/3, while the CD1 + thymocytes neither expressed IL2R
nor proliferated. The lack of proliferative responses in CD1 +
subsets is not due to the absence of CD1 - cells or factors
released by them in culture. In complementation experiments the
CD1 + subset failed to proliferate in the presence of irradiated
CD1 - double-negative thymocytes (data not shown). CD1 - 3 -
and CD1-3+ double-negative thymocytes generated CD3 +
cytotoxic cells (3,22) that killed antJ-TCR/CD3-coated targets while
the CD1 + populations did not (Table 2d). It is still possible that
differences in the ability of CD1 + and CD1 - subsets to use IL1
or bind PHA account for the CD1 + cells' unresponsiveness. We
therefore analyzed the proliferative responses of CD1 +3+ and
CD1-3+ double-negative cells to antibodies binding to well-
established membrane ligands. We found that CD1 -3+ but not
CD1+3 + double-negative cells proliferated in response to
mitogenic combinations of anti-CD2 or anti-CD3 antibodies in the
presence of IL2 (Table 3).
The findings of non-functional CD1 + double-negative thymo-
cytes and that - 9 5 % of double-positive thymocytes express CD1
on the cell membrane raised the possibility that CD1 + double-
negative thymocytes would contain precursors for CD1 +
double-positive thymocytes. That this is indeed the case is shown
in the results depicted in Fig. 2. We found that CD1 +3-4-8 +
thymocytes give rise to CD1 +3 -4 -8 - thymocytes in culture
(Fig. 2a and b). Differentiation was achieved in medium only, was
not modified by the addition of exogenous IL2, and was readily
evident after 24 h of culture. Some CD4+ and double-positive
cells started to accumulate in the culture after 36 h (Fig. 2b), and
the frequencies of double-positive cells quickly increased
thereafter (data not shown). Because the recoveries of viable cells
began to drop by - 5 0 % every 24 h, after 2 days in culture it
was difficult to discriminate whether CD1 +3-4-8+ cells acted
as intermediate precursors of such CD4 + 8+ cells. To study this
possibility, a population of CD1 +3-4-8+ thymocytes found in
normal human thymus was isolated ex vivo (Fig. 2c). We found
that after short-term culture these cells gave rise to CD1 +4 + 8 +
double-positive thymocytes (Fig 2d).
Discussion
We have studied the correlated distribution of CD1 antigen and
a/3 and yd TCR-CD3 complexes on the surface of double-
negative thymocytes and found that CD1 is acquired at early
stages of development, i.e. on some TCR-CD3- and
TCR-CD3+ double-negative thymocytes. A subset of
TCR76-CD3+ cells co-expresses CD1 in the thymus but not in
the periphery. Others have previously shown expression of CD1
on TCRa/3-CD3tow°' - double-positive cortical thymocytes but
not on peripheral T cells (4,5,9,13). CD1 expression is therefore
restricted in a/3 and y8 linkages to an intrathymic phase of
development.
The in vitro assays for function show that the CD1 + double-
negative subsets behave as inert cells whereas some cells among
either CD1 - 3 - precursors or their progeny (CD1 -3+ double-
negative thymocytes) are functionally competent. A striking
aspect of this finding is that cell responsiveness does not appear
to be associated with cell-surface TCR-CD3 expression.
Previous studies have shown that CD1 occurs on most double-
positive thymocytes which are functionally incompetent cells
despite the cell-surface expression of TCRa/3-CD3 on half of
them (4,5,9,13,28) The functional competence of some CD1 -,
TCR-CD3-4-8- thymocytes has been definitively established
with the development of several clones with such phenotype that
use the IL2 pathway of proliferation in vitro (P.Apancio etal,
unpublished observations) Our results also suggest that not all
yb T cells are born immunocompetent.
It could be argued that the binding of anti-CD1 antibody to
the cells might itself cause CD1 + thymocyte unresponsiveness
prior to assays of function However, this is ruled out by the
following (i) separation of CD1 + thymocytes by negative
selection of CDS1*1*' or CD44(Pgp-1)+ thymocytes yields also
functionally inert CD1 + cells (28,29); and (n) the addition of
saturating amounts of anti-CD1 antibodies does not inhibit cell
proliferation, IL2 secretion, or IL2-R acquisition in the Jurkat
thymoma, cells which co-expresses TCRa/3 and CD1 (A. de la
Hera, unpublished observations). We conclude that there is a
tight linkage between CD1 expression and incompetence in
assays of function in vitro among human thymocytes. Indeed,
the precursor frequencies for CD1 + cells responding to PHA
plus IL2 are always very low (< 1/100 cells), and all growing T
cells thus far studied are CD1 - (28). Also, mature a/3 and yh T
cells, of double-negative, double-positive, or single-positive
phenotypes, can be cloned from CD1 - thymocytes after
stimulation with PHA plus IL2, with high plating efficiencies in
vitro (-1/2 cells; 28 and our unpublished results).
We have studied the differentiation potential of the CD1 +3-
double-negatives. We show that they pass through a
CD3-4-8+ intermediate en route to the major (CD1 +) double-
positive thymocyte population. The precursors are IL2-R- and
do not require the addition of exogenous IL2 for their differen-
tiation. In our previous studies we removed the CD1 +
population from isolated CD4-8- thymocytes prior to culture
and hence did not find CD1 +4+8+ thymocytes (3). Similarly, in
the mouse it was shown that only the IL2-R-, Thy-I1* subset of
CD4-8- thymocytes generates immature CD4+8+ cells in vitro
(30,31). Most CD1 + double-positive thymocytes generated in
vitro bear cytoplasmic TCR/3 chain, indicating that they are a/3
pre-T cells, and some may express low levels of TCR - CD3 on
the cell membrane. CD1 + TCR-CD3+ thymocytes cannot be
expanded in vitro, nor can normal peripheral mature CD1 + T
cells be detected ex vivo (Table 1; unpublished observations).
Interestingly enough, a minor subset (<5%) of CD1-3 +
double-positives occurs in vivo We have previously shown that
polyclonal activators such as PHA and IL2 stimulate the
generation of such CD1-3+ double-positives from CD1-
double-negatives in vitro (32). CD1 -3+4+8+ thymocytes are
functionally competent and can proliferate in the presence of IL2
(32,33). We therefore conclude that CD1 + and CD1 -, CD4-8-
cells can act as precursors for two distinct subsets of double-
positive thymocytes in vitro. Experiments are underway to define
at the molecular genetic level whether the mature CD1 - double-
positives are the intermediate stage in the generation of
CD4+8- and CD4-8+ a/3 T cells (33).
In summary, CD1 antigen is expressed early in ontogeny by
double-negative thymocytes including TCR-CD3+ T cells.
CD1 + double-negative thymocytes are precursors of double-
positive thymocytes which show no functional competence in
vitro. Inducibility of IL2 pathway responsiveness in vitro occurs
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in some T cell precursors before CD1, TCR-CD3, CD4, and
CD8 expression. At later stages of development, there is a good
correlation between cell unresponsiveness in vitro and CD1
expression, both on cell-surface positive and negative a/S and
76 TCR-CD3 cells
Such studies have been performed in vitro. What can be the
putative implications of these findings to the situation in vivo? It
has been estimated that ~ 95% of thymocytes die mtrathymically,
most likely at the inert double-positive thymocyte stage (7,8) It
is generally thought that the cells that are eliminated have been
tolerized or would never terminally differentiate (7,8). The reason
that receptor occupancy leads to clonal deletion in the immature
thymocytes, instead of the clonal expansion observed in mature
T cells, is unknown, but the occupancy of CD4/CD8 has been
implicated in this process (30,34,35) We and others have
previously shown that CD1 is covalently associated with CD8 on
the surface of double-positive but not mature thymocytes, that
functionally competent CD1 + thymomas exist but do not
assemble CD1 multimolecular complexes, and that functional
CD1 - double-positive thymocytes do exist (13,32,33,36,37). In
light of these findings, we shall test the possibility that such CD1
multimolecular complex expression is, perhaps, related to the
mechanisms that lead to a selective elimination of immunologically
unresponsive cells in the thymus.
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